Alzheimer’s

In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer's patients using Glucosamine.

An analysis by MBI researchers shows that glucosamine use is associated with a 25% increase in progression from mild cognitive impairment to dementia.

Research team seeks to improve clinicians’ ability to distinguish between diseases involving dementia.

The Ed and Ethel Moore Alzheimer’s Disease Research Program supports researchers advancing discovery, prevention and treatment in dementia research.

Dr. Michael Marsiske and colleagues discovered that older adults who received brain training 20+ years ago to evaluate effects on thinking and memory continue to benefit.

In Neurology Today, Dr. Steven DeKosky weighed in on a new meta-analysis showing that levels of phosphorylated tau 217 accurately predicted the presence of amyloid in the cortex of participants.

Sessions focused on AI, breathing control, aging and traumatic brain injury — research areas of strength at UF.

MBI investigators Drs. Lien Nguyen and Laura Ranum led a team of neurogeneticists that has shed new light on the underlying causes of Alzheimer's.

Dr. Paramita Chakrabarty’s research investigates the role of neuroinflammation in Alzheimer’s disease.

The McKnight Brain Institute’s signature programs in neurological diseases include brain cancer and a range of neurodegenerative disorders including ALS, Alzheimer’s disease and Parkinson’s disease. The MBI is dedicated to accelerating discoveries in these fields to enhance brain health and develop innovative therapies. 1Florida Alzheimer’s Disease Research Center (1Florida…